logo

ADGM

Adagio Medical·NASDAQ
--
--(--)
--
--(--)
0.94 / 10
Underperform

Fundamental analysis reveals ADGM's core metrics are subpar: Revenue-MV, Net income-Revenue, Cash-MV, and ROA all rank in lower quartiles, contributing to an overall fundamental score of just 0.9/10. Only Net profit margin and Interest coverage ratio show moderate strength, but they are insufficient to offset broader weaknesses, leading to an 'Underperform' rating.

Fundamental(0.94)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.26
Score0/3
Weight13.79%
1M Return-3.84%
ROA (%)
Value-54.45
Score0/3
Weight18.81%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight6.32%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight8.92%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight15.40%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-72.60
Score0/3
Weight18.81%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight7.12%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight-15.74%
1M Return3.31%
Cash-MV
Value-0.07
Score1/3
Weight16.92%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight9.66%
1M Return-2.89%
Is ADGM fundamentally strong?
  • ADGM scores 0.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -234.17% ROE, -57771.53% net margin, -0.40 P/E ratio, -15.98 P/B ratio, and 55.34% earnings growth, these metrics solidify its Underperform investment rating.